Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc > Fridechickens prediction

<< Previous

Bullboard Posts

Next >>

Comment by FriedChickenon Mar 03, 2021 5:34pm

145 Views

Post# 32710930

RE:Fridechickens prediction

Ahhhh, so nice to see that I am haunting your dreams.

It is March! March lasts about 31 days, last time I looked at a calendar. Perhaps you should show some restraint for a few more weeks, don't get ahead of your skis.

All we need is a catalyst. Hmmmmm.....I sure do hope that something is about to happen.

Cheers,
FC

<< Previous

Bullboard Posts

Next >>

Mullen Group's Robust Case for Value, Part 1: Less-than-Truckload